# Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women

> **NCT00706225** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 30 (actual)

## Conditions studied

- Postmenopause

## Interventions

- **DRUG:** Bazedoxifene and conjugated estrogens

## Key facts

- **NCT ID:** NCT00706225
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2010-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00706225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00706225, "Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Women". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00706225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*